Moreover, we investigate the underlying mechanisms in NB that enable the STMN2.SIG to delineate immune landscapes, specifically, the interaction between STMN2+ TAMs and CD8+ Tex cells. The gene discussed is CD8A; the disease is neuroblastoma.